treatment group:Huangdai tablets
Sponsors
Changhai Hospital, Navy Military Medical University, Shanghai
Conditions
primary liver cancer
Phase 2
A phase II, open, single arm, single center study to evaluate the efficacy and safety of compound Huangdai tablets for advanced liver cancer
Active, not recruitingChiCTR2100050191
Start: 2021-10-08Updated: 2022-04-25
A phase II, open, single arm, single center study to evaluate the efficacy and safety of compound Huangdai tablets for advanced liver cancer
Active, not recruitingITMCTR2100005192
Start: 2021-10-08Updated: 2023-02-20